FDA Inspection 1081740 — Community Blood Center
The FDA completed an inspection of Community Blood Center on Feb 26, 2019 in Gladstone, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 26, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Gladstone, MO (United States)